.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
US Department of Justice
Chinese Patent Office
Colorcon
Cantor Fitzgerald
Deloitte
Citi
Medtronic
Cipla
Johnson and Johnson

Generated: December 13, 2017

DrugPatentWatch Database Preview

HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE; RESERPINE - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for hydralazine hydrochloride; hydrochlorothiazide; reserpine and what is the scope of hydralazine hydrochloride; hydrochlorothiazide; reserpine patent protection?

Hydralazine hydrochloride; hydrochlorothiazide; reserpine
is the generic ingredient in twelve branded drugs marketed by Chartwell Rx, Ivax Sub Teva Pharms, Mylan, Watson Labs, Sandoz, Solvay, Sun Pharm Industries, Lederle, and Novartis, and is included in sixteen NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty drug master file entries for hydralazine hydrochloride; hydrochlorothiazide; reserpine.

Summary for HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE; RESERPINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Ivax Sub Teva PharmsHYDROSERPINE PLUS (R-H-H)hydralazine hydrochloride; hydrochlorothiazide; reserpineTABLET;ORAL083877-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
SandozHYDRAP-EShydralazine hydrochloride; hydrochlorothiazide; reserpineTABLET;ORAL084876-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
LederleRESERPINE, HYDROCHLOROTHIAZIDE, AND HYDRALAZINE HYDROCHLORIDEhydralazine hydrochloride; hydrochlorothiazide; reserpineTABLET;ORAL087709-001May 13, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
SolvaySER-A-GENhydralazine hydrochloride; hydrochlorothiazide; reserpineTABLET;ORAL087210-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
SolvayUNIPREShydralazine hydrochloride; hydrochlorothiazide; reserpineTABLET;ORAL085893-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Watson LabsHYDROCHLOROTHIAZIDE W/ RESERPINE AND HYDRALAZINEhydralazine hydrochloride; hydrochlorothiazide; reserpineTABLET;ORAL083770-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Ivax Sub Teva PharmsHYDRALAZINE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE AND RESERPINEhydralazine hydrochloride; hydrochlorothiazide; reserpineTABLET;ORAL084291-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sun Pharm IndustriesRESERPINE, HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDEhydralazine hydrochloride; hydrochlorothiazide; reserpineTABLET;ORAL088570-001Apr 10, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Watson LabsRESERPINE, HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDEhydralazine hydrochloride; hydrochlorothiazide; reserpineTABLET;ORAL085549-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
SolvayUNIPREShydralazine hydrochloride; hydrochlorothiazide; reserpineTABLET;ORAL086298-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
Boehringer Ingelheim
Daiichi Sankyo
Accenture
Baxter
Johnson and Johnson
Moodys
Fuji
Dow
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot